Price $65.02 |
Market Cap
33.7B
|
Sector Health Care |
Div. Growth
16.40%
|
|
P/E
18.9
|
P/B
3.75
|
P/S
3.01
|
Dividend %
1.20%
|
|
P/CF
410.3
|
P/FCF
31.3
|
Op. Cash Flow
2.1M
|
FCF
1.9
|
|
Op. Margin
12.50%
|
Net Margin
7.50%
|
ROE
9.10%
|
ROI
10.90%
|
|
ROA
4.90%
|
EPS Growth
-8.20%
|
Current Ratio
2.6
|
Debt/Equity
38.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $3.56 | - | - | 146.7M | Strong Buy |
| Community Health Systems (CYH) | $3.46 | - | - | 388.4M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.19 | - | - | 40.1M | Strong Buy |
| Cardiovascular Systems Inc (CSII) | $28.79 | - | - | 1.02B | Strong Buy |
| Champions Oncology Inc (CSBR) | $10.19 | - | - | 142.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
